15,667 Shares in Vital Farms, Inc. (NASDAQ:VITL) Acquired by Sigma Planning Corp

Sigma Planning Corp bought a new position in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 15,667 shares of the company's stock, valued at approximately $477,000.

Several other large investors have also added to or reduced their stakes in the business. CIBC Private Wealth Group LLC lifted its stake in Vital Farms by 152.1% in the fourth quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after acquiring an additional 540 shares during the last quarter. Frazier Financial Advisors LLC bought a new position in shares of Vital Farms in the fourth quarter valued at about $59,000. CWM LLC raised its position in shares of Vital Farms by 43.2% in the first quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after purchasing an additional 650 shares during the period. Union Bancaire Privee UBP SA bought a new position in shares of Vital Farms in the first quarter valued at about $112,000. Finally, Hanson & Doremus Investment Management bought a new position in shares of Vital Farms in the first quarter valued at about $130,000. Institutional investors and hedge funds own 98.59% of the company's stock.

Insider Activity

In other news, insider Matthew Ohayer sold 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00. Following the sale, the insider directly owned 6,858,890 shares in the company, valued at approximately $268,662,721.30. This trade represents a 0.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Thilo Wrede sold 1,200 shares of the firm's stock in a transaction that occurred on Friday, July 11th. The shares were sold at an average price of $38.97, for a total transaction of $46,764.00. Following the completion of the sale, the chief financial officer owned 56,187 shares in the company, valued at approximately $2,189,607.39. The trade was a 2.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 86,400 shares of company stock worth $2,996,250. Insiders own 21.30% of the company's stock.

Vital Farms Stock Performance

NASDAQ:VITL traded up $0.05 during mid-day trading on Friday, reaching $37.40. 350,186 shares of the company's stock were exchanged, compared to its average volume of 1,022,286. Vital Farms, Inc. has a one year low of $27.91 and a one year high of $45.72. The firm has a market capitalization of $1.67 billion, a PE ratio of 33.39 and a beta of 0.94. The business's fifty day simple moving average is $35.21 and its two-hundred day simple moving average is $35.26. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.91 and a current ratio of 3.35.

Vital Farms (NASDAQ:VITL - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.26 by $0.11. Vital Farms had a net margin of 8.26% and a return on equity of 19.53%. The firm had revenue of $162.19 million for the quarter, compared to analyst estimates of $164.43 million. During the same period last year, the firm earned $0.43 EPS. The business's quarterly revenue was up 9.7% compared to the same quarter last year. Analysts anticipate that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Analyst Ratings Changes

VITL has been the topic of several research analyst reports. Mizuho initiated coverage on shares of Vital Farms in a research report on Tuesday, July 8th. They issued an "outperform" rating and a $45.00 price objective on the stock. Telsey Advisory Group reissued an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a research report on Monday, May 5th. Morgan Stanley dropped their price objective on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Finally, BMO Capital Markets raised shares of Vital Farms to a "strong-buy" rating in a research report on Tuesday, May 6th. Nine equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $44.67.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.